Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes
Conclusions:
Exenatide once weekly improved glycemic parameters independent of weight change, although the magnitude of improvement increased with increasing weight loss. The greatest trend of improvement in glycemic parameters, cardiovascular risk factors including systolic BP, LDL-C, total cholesterol, and triglycerides, and in liver enzymes, was seen in the patient quartiles with the greatest reductions in body weight.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Lawrence BlondeRichard PencekLeigh MacConell Source Type: research
More News: Byetta | Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Gastroenterology | Heart | Legislation | Liver | Obesity | Study | Urology & Nephrology | Weight Loss